Skip to main navigation menu Skip to main content Skip to site footer

Vol. 1 No. 15 (2023)
Academic International Conference on Multi-Disciplinary Studies and Education

Articles

CHARACTERISTIC FEATURES OF RISK FACTORS IN CHRONIC ISCHEMIA OF THE BRAIN.

Published 2023-09-03

  • Abdurasulova Nozima Abduvokhidovna

Abstract

Chronic brain ischemia (SMI) is a specific type of vascular brain pathology caused by gradual progressive diffuse disruption of the blood supply to the brain, as a result of which it is expressed by the development of various defects [4,5]. Stress and depression are a manifestation of SMI. Stress-(derived from English, meaning "stress" - voltage) is a protective reaction of an organism manifested by neuroendocrine and metabolic processes in response to exogenous and endogenous influences. The relevance of the study of asthenia and the earliest detection in patients at risk of developing tserebrovascular diseases is explained by the fact that the first stage of SMI is the presence of Asthenic Syndrome. Headache and heaviness in the head, dizziness, general weakness, increased fatigue, emotional lability, sleep disorders, decreased performance - symptoms characteristic of the initial manifestation of cerebral circulatory failure are evidence that asthenic siindrome is nothing more than a head.

PDF

References

  1. . Bilenko M. V. theoretical and experimental foundations of the use of antioxidant therapy to prevent acute ischemic injuries in organs // Bioantioxifiers in the regulation of metabolism in the norm and pathology. M., 1982. Pp. 195-213.
  2. Boldyrev A. A. oxidative stress and brain / / Soros training journal. 2001. No. 7. Pp. 21-27.
  3. Lapin I. P. Neurochemical mosaic of individualization of anxiety and psychopharmacology / / anxiety and obsessions. Moscow: Rams publishing, 1998. Pp. 12-20.
  4. Putilina M. V. possibilities of early drug correction of mental and autonomic disorders in hypertensive encephalopathy / / doctor. 2009. No. 9. Pp. 38-42.
  5. Putilina M. V. neuroprotective therapy of chronic brain ischemia / / physician. 2008. No. 9. Pp. 34-38.
  6. Smirnova I. N., Suslina Z. A., Tanashyan M. M. et al. Antioxidant and neurotrophic effects of cytoflavin in chronic cerebrovascular diseases // Bulletin of the St. Petersburg State Medical Academy. I. I. Mechnikov Academy. 2002. No. 3. Pp. 110-114.
  7. Voronina T. A., Smirnov L. D., Goryainova I. I. mechanism of action and justification of the use of the drug Mexidol in neurology. M., 2000. p. 14.
  8. Fedorova T. N. oxidative stress and protection of the brain from ischemic injury): dis. ... Doc. biol. nauk. M., 2004.
  9. Rickels K, Downing R, Schweizer E, Hassman H. Antidepressants for the treatment of generalized anxiety disorder. A placebo–controlled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry 1993; 50(11): 884–895;
  10. Salomova, N. K. (2022). Risk factors for recurrent stroke. Polish journal of science N, 52, 33-35.